Alpine Bank Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
8,036
-4
-0% -$932 0.26% 59
2026
Q1
$1.97M Buy
8,040
+89
+1% +$20.7K 0.29% 53
2025
Q4
$1.65M Buy
7,951
+700
+10% +$138K 0.23% 55
2025
Q3
$1.34M Sell
7,251
-26
-0.4% -$4.45K 0.19% 66
2025
Q2
$1.11M Sell
7,277
-631
-8% -$97K 0.17% 66
2025
Q1
$1.31M Buy
+7,908
New +$1.24M 0.21% 60
2024
Q3
$1.27M Buy
+7,858
New +$1.25M 0.2% 62

Other funds holding JNJ

Alpine Bank Wealth Management's JNJ Position: Q2 2026 in Review

Alpine Bank Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.05% in Q2 2026, selling an estimated $932 and leaving 8,036 shares worth $2.04M. The position accounts for 0.26% of the portfolio, ranked #59.

Alpine Bank Wealth Management first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. 4,691 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Alpine Bank Wealth Management held 8,036 shares of Johnson & Johnson worth $2.04M as of Q2 2026.
  • Alpine Bank Wealth Management sold 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
  • Johnson & Johnson made up 0.26% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #59 holding.
  • Alpine Bank Wealth Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • 4,691 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.